• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

Matters of the Heart: Images of Cardiac Disorders Myxedema Heart

News
Article

Over the previous 6 months, a59-year-old man had experienced lethargy,fatigue, poor appetite, cold intolerance,and abdominal distention. Hisvital signs were normal; physical examinationrevealed periorbital andpretibial edema, distant heart sounds,and delayed reflexes.

Over the previous 6 months, a59-year-old man had experienced lethargy,fatigue, poor appetite, cold intolerance,and abdominal distention. Hisvital signs were normal; physical examinationrevealed periorbital andpretibial edema, distant heart sounds,and delayed reflexes.An ECG showed low voltages,and a chest film revealed generalizedenlargement of the cardiac silhouettewith a globular configuration andsmall, bilateral, pleural effusions (A).An echocardiogram confirmed thepresence of a large pericardial effusion.Subsequent laboratory studiesrevealed serum levels of thyroid-stimulatinghormone of 50 μU/mL and ofthyroxine, 4.5 μg/dL; and a reversetriiodothyronine uptake of 24.7 ng/dL.These findings are consistent withprimary hypothyroidism. Thyroidhormone replacement therapy wasinitiated. One year later, the chestfilm changes had resolved (B).The recognition of pericardial effusionsis important, because thesemay, in a short time, lead to cardiactamponade. Causes of such effusionsinclude trauma, pericarditis, renal failure,Dressler syndrome, neoplasticdisease, and immunologic disease(particularly rheumatoid arthritis andsystemic lupus erythematosus). Pericardialeffusion is a common findingin myxedema, occurring in up to onethird of all cases.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2025 MJH Life Sciences

All rights reserved.